Related Experiment Video
Updated: May 9, 2025
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Crossing the Valley of Death in Spinal Cord Injury: Learning from Successful Translators
Vieri Failli1, Stephen M Strittmatter2, Martin E Schwab3
1Wings for Life, Salzburg, Austria.
Abstract:
A straightforward path to successful scientific translation remains uncharted, particularly in a complex progressive condition such as spinal cord injury (SCI), which affects multiple body functions simultaneously. Evolving regulatory requirements add to the complexity and expense of attaining a treatment that is both safe and efficacious. Although rare, there are examples of SCI scientists who have successfully navigated the "valley of death" from discovery science to completed clinical trials. This article reflects the translational journey of five SCI scientists who have encountered similar and different scenarios while striving to launch or complete a clinical trial. Learning from these experiences has identified lessons learned and gaps, particularly with respect to funding and support for SCI translation.
Insights
Navigating scientific translation for spinal cord injury (SCI) treatments is complex. Lessons learned from five SCI scientists highlight funding and support gaps in advancing discoveries to clinical trials.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Clinical Translation
Background:
- Spinal cord injury (SCI) is a complex condition affecting multiple body functions.
- Translating scientific discoveries into effective treatments faces significant hurdles.
- Evolving regulatory requirements increase the complexity and cost of treatment development.
Purpose of the Study:
- To explore the translational journeys of five scientists in spinal cord injury research.
- To identify common and unique challenges encountered during clinical trial progression.
- To learn from these experiences to improve future SCI treatment development.
Main Methods:
- Qualitative analysis of five individual translational case studies.
- Interviews and reflections from SCI researchers involved in clinical trials.
- Identification of recurring themes and critical success factors.
Main Results:
- Successful navigation from discovery to clinical trials is challenging but achievable.
- Key obstacles include funding, regulatory navigation, and interdisciplinary collaboration.
- Varied experiences highlight the need for tailored support systems.
Conclusions:
- Significant gaps exist in funding and support for spinal cord injury (SCI) translation.
- Learning from successful and unsuccessful translational efforts is crucial.
- A more streamlined and supportive pathway is needed to advance SCI therapies.
More Related Videos
08:05Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
Published on: November 3, 2017
09:14Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
Published on: April 5, 2016
